| TDI |
Table TDI-0. Data sources for clients entering treatment
|
table |
| TDI |
Table TDI-1. Clients entering treatment and reporting treatment units by country, 2007 or most recent year available
|
table |
| TDI |
Table TDI-2. Clients entering treatment and reporting treatment units, 1997 to 2007
Part (i) New clients by country and year of treatment
|
table |
| TDI |
Table TDI-2. Clients entering treatment and reporting treatment units, 1997 to 2007
Part (ii) All clients by country and year of treatment
|
table |
| TDI |
Table TDI-2. Clients entering treatment and reporting treatment units, 1997 to 2007
Part (iii) Reporting treatment units by country and year of treatment
|
table |
| TDI |
Table TDI-2. Clients entering treatment and reporting treatment units, 1997 to 2007
Part (iv) Types of reporting treatment unit by country
|
table |
| TDI |
Table TDI-3. New clients entering treatment by primary drug, 1997 to 2007
Part (i) New heroin clients by country and year of treatment (%)
|
table |
| TDI |
Table TDI-3. New clients entering treatment by primary drug, 1997 to 2007
Part (ii) New cocaine clients by country and year of treatment (%)
|
table |
| TDI |
Table TDI-3. New clients entering treatment by primary drug, 1997 to 2007
Part (iii) New stimulants (amphetamines and MDMA) clients by country and year of treatment (%)
|
table |
| TDI |
Table TDI-3. New clients entering treatment by primary drug, 1997 to 2007
Part (iv) New cannabis clients by country and year of treatment (%)
|
table |
| TDI |
Table TDI-4. Demographic characteristics of clients entering treatment, 2007 or most recent year available
Part (i) New clients by country and gender (%)
|
table |
| TDI |
Table TDI-4. Demographic characteristics of clients entering treatment, 2007 or most recent year available
Part (ii) All clients by country and gender (%)
|
table |
| TDI |
Table TDI-4. Demographic characteristics of clients entering treatment, 2007 or most recent year available
Part (iii) New clients by country and age (%)
|
table |
| TDI |
Table TDI-4. Demographic characteristics of clients entering treatment, 2007 or most recent year available
Part (iv) All clients by country and age (%)
|
table |
| TDI |
Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2007 or most recent year available
Part (i) New clients by country and primary drug (%)
|
table |
| TDI |
Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2007 or most recent year available
Part (ii) All clients by country and primary drug (%)
|
table |
| TDI |
Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2007 or most recent year available
Part (iii) New clients by country and rates of injection of primary drug (%)
|
table |
| TDI |
Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2007 or most recent year available
Part (iv) All clients by country and rates of injection of primary drug (%)
|
table |
| TDI |
Table TDI-6. Incidence of treatment demand for drug use, 2007 or most recent year available — new clients by country (rate per 100 000 population)
|
table |
| TDI |
Table TDI-7. Data coverage, 2007 or most recent year available
Part (i) Clients entering treatment by country and type of treatment centre and type of client
|
table |
| TDI |
Table TDI-7. Data coverage, 2007 or most recent year available
Part (ii) Units by country and type of treatment centre and reporting status
|
table |
| TDI |
Table TDI-8. Primary use of stimulants of clients entering treatment, 2007 or most recent year available
Part (i) New clients by country and type of stimulant (%)
|
table |
| TDI |
Table TDI-8. Primary use of stimulants of clients entering treatment, 2007 or most recent year available
Part (ii) All clients by country and type of stimulant (%)
|
table |
| TDI |
Table TDI-9. Demographic characteristics of clients entering outpatient treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and gender
|
table |
| TDI |
Table TDI-9. Demographic characteristics of clients entering outpatient treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and by gender
|
table |
| TDI |
Table TDI-9. Demographic characteristics of clients entering outpatient treatment, 2007 or most recent year available
Part (iii) New outpatient clients by country and age
|
table |
| TDI |
Table TDI-9. Demographic characteristics of clients entering outpatient treatment, 2007 or most recent year available
Part (iv) All outpatient clients by country and age
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients, age distribution by primary drug (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (ii) New outpatient clients, primary drug distribution by age (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (iii) All outpatient clients, age distribution by primary drug (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (iv) All outpatient clients, primary drug distribution by age (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (v) New inpatient clients, age distribution by primary drug (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (vi) New inpatient clients, primary drug distribution by age (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (vii) All inpatient clients, age distribution by primary drug (%)
|
table |
| TDI |
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available
Part (viii) All inpatient clients, primary drug distribution by age (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients, age at first use distribution by primary drug (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (ii) New outpatient clients, primary drug distribution by age at first use (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (iii) All outpatient clients, age at first use distribution by primary drug (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (iv) All outpatient clients, primary drug distribution by age at first use (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (v) New inpatient clients, age at first use distribution by primary drug (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (vi) New inpatient clients, primary drug distribution by age at first use (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (vii) All inpatient clients, age at first use distribution by primary drug (%)
|
table |
| TDI |
Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available
Part (viii) All inpatient clients, primary drug distribution by age at first use (%)
|
table |
| TDI |
Table TDI-12. Education status of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and education status (%)
|
table |
| TDI |
Table TDI-12. Education status of clients entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and education status (%)
|
table |
| TDI |
Table TDI-12. Education status of clients entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients by country and education status (%)
|
table |
| TDI |
Table TDI-12. Education status of clients entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients by country and education status (%)
|
table |
| TDI |
Table TDI-13. Labour status of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and labour status (%)
|
table |
| TDI |
Table TDI-13. Labour status of clients entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and labour status (%)
|
table |
| TDI |
Table TDI-13. Labour status of clients entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients by country and labour status (%)
|
table |
| TDI |
Table TDI-13. Labour status of clients entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients by country and labour status (%)
|
table |
| TDI |
Table TDI-14. Persons with whom client is living on entering treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and with whom living (%)
|
table |
| TDI |
Table TDI-14. Persons with whom client is living on entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and with whom living (%)
|
table |
| TDI |
Table TDI-14. Persons with whom client is living on entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients by country and with whom living (%)
|
table |
| TDI |
Table TDI-14. Persons with whom client is living on entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients by country and with whom living (%)
|
table |
| TDI |
Table TDI-15. Percentage distribution of living conditions for clients entering treatment in 2007
Part (i) New clients entering outpatient treatment
|
table |
| TDI |
Table TDI-15. Percentage distribution of living conditions for clients entering treatment in 2007
Part (ii) All clients entering outpatient treatment
|
table |
| TDI |
Table TDI-15. Percentage distribution of living conditions for clients entering treatment in 2007
Part (iii) New clients entering inpatient treatment
|
table |
| TDI |
Table TDI-15. Percentage distribution of living conditions for clients entering treatment in 2007
Part (iv) All clients entering inpatient treatment
|
table |
| TDI |
Table TDI-16. Source of referral of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and source of referral (%)
|
table |
| TDI |
Table TDI-16. Source of referral of clients entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and source of referral (%)
|
table |
| TDI |
Table TDI-16. Source of referral of clients entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients by country and source of referral (%)
|
table |
| TDI |
Table TDI-16. Source of referral of clients entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients by country and source of referral (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (i) New opioid outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (ii) All opioid outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (iii) New cocaine (HCl and crack) outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (iv) All cocaine (HCl and crack) outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (v) New stimulants (other than cocaine) outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (vi) All stimulants (other than cocaine) outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (vii) New hypnotics and sedatives outpatient clients by country and usual route of administration (%)
|
table |
| TDI |
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2007 or most recent year available
Part (viii) All hypnotics and sedatives outpatient clients by country and usual route of administration
|
table |
| TDI |
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients by primary drug and frequency of use (%)
|
table |
| TDI |
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients by primary drug and frequency of use (%)
|
table |
| TDI |
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients by primary drug and frequency of use (%)
|
table |
| TDI |
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients by primary drug and frequency of use (%)
|
table |
| TDI |
Table TDI-19. Primary drug of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and primary drug (%)
|
table |
| TDI |
Table TDI-19. Primary drug of clients entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and primary drug (%)
|
table |
| TDI |
Table TDI-19. Primary drug of clients entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients by country and primary drug (%)
|
table |
| TDI |
Table TDI-19. Primary drug of clients entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients by country and primary drug (%)
|
table |
| TDI |
Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2007 or most recent year available
Part (i) New outpatient clients, ratio of males to females by country and primary drug
|
table |
| TDI |
Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2007 or most recent year available
Part (ii) All outpatient clients, ratio of males to females by country and primary drug
|
table |
| TDI |
Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2007 or most recent year available
Part (iii) New inpatient clients, ratio of males to females by country and primary drug
|
table |
| TDI |
Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2007 or most recent year available
Part (iv) All inpatient clients, ratio of males to females by country and primary drug
|
table |
| TDI |
Table TDI-22. Secondary drugs cited by clients entering treatment, 2007 or most recent year available
Part (i) Outpatient units
|
table |
| TDI |
Table TDI-22. Secondary drugs cited by clients entering treatment, 2007 or most recent year available
Part (ii) Inpatient units
|
table |
| TDI |
Table TDI-24. Type of treatment centre by primary drug of clients entering treatment, 2007 or most recent year available
Part (i) New clients by country and primary drug and type of treatment centre (%)
|
table |
| TDI |
Table TDI-24. Type of treatment centre by primary drug of clients entering treatment, 2007 or most recent year available
Part (ii) All clients by country and primary drug and type of treatment centre (%)
|
table |
| TDI |
Table TDI-25. Percentage distribution of age by gender among all clients entering outpatient treatment with primary drug: opioids, cocaine, stimulants and cannabis in 2007 for countries supplying data
|
table |
| TDI |
Table TDI-32. Mean age by gender by primary drug among all clients entering outpatient and inpatient treatment in 2007
Part (i) Outpatient clients
|
table |
| TDI |
Table TDI-32. Mean age by gender by primary drug among all clients entering outpatient and inpatient treatment in 2007
Part (ii) Inpatient clients
|
table |
| TDI |
Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2007
Part (i) Outpatient treatment centres
|
table |
| TDI |
Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2007
Part (ii) Inpatient treatment centres
|
table |
| TDI |
Table TDI-36. Primary amphetamine use among new clients entering treatment (%), 2002 to 2007
|
table |
| TDI |
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available
Part (i) All clients by country and primary drug and type of treatment unit
|
table |
| TDI |
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available
Part (ii) Outpatient clients by primary drug and mean age and gender ratio
|
table |
| TDI |
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available
Part (iii) Inpatient clients by primary drug and mean age and gender ratio
|
table |
| TDI |
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available
Part (iv) Outpatient clients by secondary drug and primary drug
|
table |
| TDI |
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available
Part (v) Inpatient clients by secondary drug and primary drug
|
table |
| TDI |
Table TDI-38. Primary opioid users and the proportion of opioid injectors among drug clients in 2007 or most recent year available in all types of treatment centres in 14 countries
Part (i) Number of primary opioids clients
|
table |
| TDI |
Table TDI-38. Primary opioid users and the proportion of opioid injectors among drug clients in 2007 or most recent year available in all types of treatment centres in 14 countries
Part (ii) % of primary opioids clients
|
table |
| TDI |
Table TDI-38. Primary opioid users and the proportion of opioid injectors among drug clients in 2007 or most recent year available in all types of treatment centres in 14 countries
Part (iii) % of opioids injectors
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (i) New opioid outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (ii) New cocaine (HCI and 'crack') outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (iii) New stimulants (other than cocaine) outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (iv) New hallucinogen outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (v) New hypnotics and sedatives outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (vi) New volatile inhalant outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (vii) New cannabis outpatient clients by country and age
|
table |
| TDI |
Table TDI-102. New clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (viii) New 'other drugs' outpatient clients by country and by age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (i) All opioid outpatient clients by country and ag
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (ii) All cocaine (HCI and 'crack') outpatient clients by country and age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (iii) All stimulants (other than cocaine) outpatient clients by country and age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (iv) All hallucinogen outpatient clients by country and age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (v) All hypnotics and sedatives outpatient clients by country and age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (vi) All volatile inhalant outpatient clients by country and age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (vii) All cannabis outpatient clients by country and age
|
table |
| TDI |
Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2007 or most recent year available
Part (viii) All 'other drugs' outpatient clients by country and by age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (i) New opioid inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (ii) New cocaine (HCI and 'crack') inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (iii) New stimulants (other than cocaine) inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (iv) New hallucinogen inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (v) New hypnotics and sedatives inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (vi) New volatile inhalant inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (vii) New cannabis inpatient clients by country and age
|
table |
| TDI |
Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (viii) New 'other drugs' inpatient clients by country and by age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (i) All opioid inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (ii) All cocaine (HCI and 'crack') inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (iii) All stimulants (other than cocaine) inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (iv) All hallucinogen inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (v) All hypnotics and sedatives inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (vi) All volatile inhalant inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (vii) All cannabis inpatient clients by country and age
|
table |
| TDI |
Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2007 or most recent year available
Part (viii) All 'other drugs' inpatient clients by country and by age
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (i) New opioid outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (ii) New cocaine (HCI and 'crack') outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iii) New stimulants (other than cocaine) outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iv) New hallucinogen outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (v) New hypnotics and sedatives outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vi) New volatile inhalant outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vii) New cannabis outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (viii) New 'other drugs' outpatient clients by country and by age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (i) All opioid outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (ii) All cocaine (HCI and 'crack') outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iii) All stimulants (other than cocaine) outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iv) All hallucinogen outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (v) All hypnotics and sedatives outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vi) All volatile inhalant outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vii) All cannabis outpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (viii) All 'other drugs' outpatient clients by country and by age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (i) New opioid inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (ii) New cocaine (HCI and 'crack') inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iii) New stimulants (other than cocaine) inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iv) Number of clients using hallucinogens as primary drug
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (v) New hypnotics and sedatives inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vi) New volatile inhalant inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vii) New cannabis inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (viii) New 'other drugs' inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (i) All opioid inpatient clients by country and age at first
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (ii) All cocaine (HCI and 'crack') inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iii) All stimulants (other than cocaine) inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (iv) All hallucinogen inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (v) All hypnotics and sedatives inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vi) All volatile inhalant inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (vii) All cannabis inpatient clients by country and age at first use
|
table |
| TDI |
Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2007 or most recent year available
Part (viii) All 'other drugs' inpatient clients by country and by age at first use
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (i) New opioid outpatient clients by country and frequency of use (%
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (ii) All opioid outpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (iii) New cocaine (HCI and ‘crack’) outpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (viii) All cannabis outpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (iv) All cocaine (HCI and ‘crack’) outpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (v) New stimulants (other than cocaine) outpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (vi) All stimulants (other than cocaine) outpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2007 or most recent year available
Part (vii) Percentage distribution amongst new clients with cannabis as primary drug
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (i) New opioid inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (ii) All opioid inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (iii) New cocaine (HCI and ‘crack’) inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (iv) All cocaine (HCI and ‘crack’) inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (v) New stimulants (other than cocaine) inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (vi) All stimulants (other than cocaine) inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (vii) Percentage distribution amongst new clients with cannabis as primary drug
|
table |
| TDI |
Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2007 or most recent year available
Part (viii) All cannabis inpatient clients by country and frequency of use (%)
|
table |
| TDI |
Table TDI-113. All clients entering treatment for opioids by country and type of opioid misused (%), 2007 or most recent year available
|
table |
| TDI |
Table TDI-114. Primary opioids distribution among all clients entering treatment by country and type of treatment centre (%), 2007
|
table |
| TDI |
Table TDI-115. HCL and crack use of clients entering outpatient treatment, 2007 or most recent year available
Part (i) New outpatient clients by country and type of cocaine product
|
table |
| TDI |
Table TDI-115. HCL and crack use of clients entering outpatient treatment, 2007 or most recent year available
Part (ii) All outpatient clients by country and type of cocaine product
|
table |